Hydroxychloroquine and a low activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects.

Osteoporosis is incurable because there are no dual antiresorptive and anabolic therapeutic agents that can be administered long-term. The most widely used antiresorptive agents, bisphosphonates (BPs), also inhibit bone formation and thus have limited effect in preventing osteoporotic fracture. Hydroxychloroquine (HCQ), which is used to treat rheumatoid arthritis, prevents the lysosomal degradation of TNF receptor-associated factor 3 (TRAF3), an NF-κB adaptor protein that limits bone resorption and maintains bone formation. We attempted to covalently link HCQ to a hydroxyalklyl BP (HABP) with anticipated low antiresorptive activity, to target delivery of HCQ to bone to test if this targeting increases its efficacy to prevent TRAF3 degradation in the bone microenvironment and thus reduce bone resorption and increase bone formation, while reducing its systemic side effects. Unexpectedly, HABP-HCQ was found to exist as a salt in aqueous solution, composed of a protonated HCQ cation and a deprotonated HABP anion. Nevertheless, it inhibited osteoclastogenesis, stimulated osteoblast differentiation, and increased TRAF3 protein levels in vitro. HABP-HCQ significantly inhibited both osteoclast formation and bone marrow fibrosis in mice given multiple daily PTH injections. In contrast, HCQ inhibited fibrosis, but not osteoclast formation, while the HABP alone inhibited osteoclast formation, but not fibrosis, in the mice. HABP-HCQ, but not HCQ, prevented trabecular bone loss following ovariectomy in mice and, importantly, increased bone volume in ovariectomized mice with established bone loss because HABP-HCQ increased bone formation and decreased bone resorption parameters simultaneously. In contrast, HCQ increased bone formation, but did not decrease bone resorption parameters, while HABP also restored the bone lost in ovariectomized mice, but it inhibited parameters of both bone resorption and formation. Our findings suggest that the combination of HABP and HCQ could have dual antiresorptive and anabolic effects to prevent and treat osteoporosis.

A fluorescent chemosensor for selective detection of chromium (III) ions in environmentally and biologically relevant samples.

A simple single step one pot multicomponent reaction was performed to synthesize N-(tert-butyl)-2-(furan-2-yl)imidazo[1,2-a]pyridine-3-amine (TBFIPA). The synthesized TBFIPA was subjected to library of cations to study its ability for selective and sensitive detection of specific metal ions. Selective detection of chromium ions by TBFIPA were found from the significant hypsochromic shift (335 nm â†’ 285 nm) in the UV-Visible spectra. The fluorescent TBFIPA displays complete quenching of fluorescence under UV lamp (365 nm) only in the presence of chromium without the interference of common metal ions. Binding constant (ka) obtained from Benesi-Hildebrand plot is 0.21 × 105 M-1, limit of detection (LOD) and limit of quantification (LOQ) of TBFIPA toward Cr3+ ions are 4.70 × 10-7 M and 1.56 × 10-7 M, respectively. The mechanism proposed during complex formation were supported by stoichiometric Job continuous variation plot, 1H NMR titration and ESI-MS spectroscopic data. All the experimental confirmation for complex formation were corroborated with theoretical DFT studies optimized using RB3LYP/6-31G(d) basis set. The selectivity and sensitivity of TBFIPA toward Cr3+ ions are found suitable to design a user-friendly silica based portable test kit. Alongside, TBFIPA was successfully utilized for imaging onion epidermal cells. Furthermore, the results obtained for biological, environmental, and industrial samples provided solid evidence to estimate chromium ions using TBFIPA in these real samples.

Development of an environmentally sustainable technique to minimize the sludge production in the textile effluent sector through an electrokinetic (EK) coupled with electrooxidation (EO) approach.

This study presents an environmentally sustainable method for minimizing sludge production in the textile effluent sector through the combined application of electrokinetic (EK) and electrooxidation (EO) processes. AAS and XRF analyses reveal that utilizing acidic electrolytes in the EK method successfully eliminates heavy metals (Cu, Mn, Zn, and Cr) from sludge, demonstrating superior efficiency compared to alkaline conditions. In addition, the total removal efficiency of COD contents was calculated following the order of EK-3 (60%), EK-1 (51%) and EK-2 (34%). Notably, EK-3, leveraging pH gradient fluctuations induced by anolyte in the catholyte reservoir, outperforms other EK systems in removing COD from sludge. The EK process is complemented by the EO process, leading to further degradation of dye and other organic components through the electrochemical generation of hypochlorite (940 ppm). At an alkaline pH of 10.0, the color and COD removal were effectively achieved at 98 and 70% in EO treatment, compared to other mediums. In addition, GC-MS identified N-derivative residues at the end of the EO. This study demonstrates an integrated approach that effectively eliminates heavy metals and COD from textile sludge, combining EK with EO techniques.